Produktinformation
- 19-Nor-5α,17α-pregn-20-yne-3β,17-diol (6CI,7CI,8CI)
- 17α-Ethynyl-5α-estrane-3β,17β-diol
- 17α-Ethynyl-5α-oestrane-3β,17β-diol
- 19-Norpregn-20-yne-3,17-diol
- (3β,5α,17α)-
- 5alpha-Estran-17alpha-ethinyl-3beta,17beta-diol
Applications A 3β-metabolite of progesterone receptor agonist Norethindrone (N676000) that acts as a estrogen receptor agonist in osteoblastic cells. It also has novel nongenomic endothelium-independent vasorelaxing effects.
References Lemus, A.E. et al.: J. Endocrinol., 200, 199 (2009); Perusquia, M. et al.: Eur. J. Pharmacol., 475, 161 (2003); Blom, M.J. et al.: Drug Metab. Disp., 29, 976 (2001);